Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Howard

Showing results (161-170 of 266) with videos related to

Pageof 27
Sort By:
Journal of the American Geriatrics Society|October 9, 2002
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's diseaseMarco Catani, Patrizia Mecocci, Roberto Tarducci, et al.
Nature Communications|April 7, 2020
Noradrenergic-dependent functions are associated with age-related locus coeruleus signal intensity differencesKathy Y Liu, Rogier A Kievit, Kamen A Tsvetanov, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 16, 2025
Three approaches to determining clinically meaningful benefit on the Cohen-Mansfield Agitation Inventory in dementia clinical trials for agitationKathy Y Liu, Chineze Ivenso, Rebecca Howard, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 18, 2023
Navigating polycrisis: long-run socio-cultural factors shape response to changing climateDaniel Hoyer, James S Bennett, Jenny Reddish, et al.
Journal of the American Medical Directors Association|November 7, 2015
The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled TrialAnne Corbett, Adrian Owen, Adam Hampshire, et al.
Trials|August 1, 2022
Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendmentsKaren Hoang, Hilary Watt, Mara Golemme, et al.
Psychiatry Research|December 27, 2005
Tract-specific anisotropy measurements in diffusion tensor imagingRichard A Kanaan, Sukhwinder S Shergill, Gareth J Barker, et al.
Plos One|June 8, 2017
Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohortElizabeth Baker, Ehtesham Iqbal, Caroline Johnston, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 5, 2022
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysisMichael C B David, Martina Del Giovane, Kathy Y Liu, et al.
Brain Communications|November 10, 2023
Heart rate variability and risk of agitation in Alzheimer's disease: the Atherosclerosis Risk in Communities StudyKathy Y Liu, Eric A Whitsel, Gerardo Heiss, et al.
Pageof 27

Showing results (161-170 of 266) with videos related to

Sort By:
Pageof 27
Journal of the American Geriatrics Society|October 9, 2002
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's diseaseMarco Catani, Patrizia Mecocci, Roberto Tarducci, et al.
Nature Communications|April 7, 2020
Noradrenergic-dependent functions are associated with age-related locus coeruleus signal intensity differencesKathy Y Liu, Rogier A Kievit, Kamen A Tsvetanov, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 16, 2025
Three approaches to determining clinically meaningful benefit on the Cohen-Mansfield Agitation Inventory in dementia clinical trials for agitationKathy Y Liu, Chineze Ivenso, Rebecca Howard, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 18, 2023
Navigating polycrisis: long-run socio-cultural factors shape response to changing climateDaniel Hoyer, James S Bennett, Jenny Reddish, et al.
Journal of the American Medical Directors Association|November 7, 2015
The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled TrialAnne Corbett, Adrian Owen, Adam Hampshire, et al.
Trials|August 1, 2022
Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendmentsKaren Hoang, Hilary Watt, Mara Golemme, et al.
Psychiatry Research|December 27, 2005
Tract-specific anisotropy measurements in diffusion tensor imagingRichard A Kanaan, Sukhwinder S Shergill, Gareth J Barker, et al.
Plos One|June 8, 2017
Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohortElizabeth Baker, Ehtesham Iqbal, Caroline Johnston, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 5, 2022
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysisMichael C B David, Martina Del Giovane, Kathy Y Liu, et al.
Brain Communications|November 10, 2023
Heart rate variability and risk of agitation in Alzheimer's disease: the Atherosclerosis Risk in Communities StudyKathy Y Liu, Eric A Whitsel, Gerardo Heiss, et al.
Pageof 27